KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−10.3x

Market Cap

$1.50B

MomentumView details →

1D Return

+1.87%

YTD Return

−4.07%

RSI (14)

46.9

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−10.3x

Market Cap

$1.50B

RSI (14)

46.9

MomentumView details →

1D Return

+1.87%

YTD Return

−4.07%

SummaryUpdated Apr 1, 2026

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) is a wearable medical device and digital healthcare company founded in 2014 and headquartered in Kirkland, Washington. The company went public in March 2025 and focuses on transforming patient outcomes in cardiovascular disease through innovative monitoring and therapeutic intervention technologies. Kestra specializes in developing connected medical devices that are designed to be intuitive and intelligent, with their primary focus on protecting patients at elevated risk of sudden cardiac arrest.

Ask drillr about KESTRA MEDICAL TECHNOLOGIES, LTD. →

ProfitabilityView details →

Gross Margin

51.37%

Net Margin

−138.36%

EBITDA Margin

−137.42%

ROE (TTM)

−50.69%

ROA (TTM)

−36.72%

Asset Turnover

0.26x

GrowthView details →

Revenue YoY

+59.03%

EPS YoY

+33.52%

FCF YoY

−15.21%

Revenue CAGR 3Y

+131.88%

EPS CAGR 3Y

+52.63%

EBITDA YoY

−32.18%

EarningsView details →

EPS (Actual)

−$0.61

EPS Surprise

−2.32%

Beats (12Q)

1/12

Next Q EPS Est

−$0.60

Avg Surprise (4Q)

5.75%

Rev Surprise

−7.28%

Capital & dividendView details →

Debt/Equity

0.18x

Current Ratio

4.41x

Quick Ratio

4.28x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

95.13M

Net Income (TTM)

−131.61M

Op. CF (TTM)

−81.70M

Latest newsMore news →

Kestra Medical Technologies announced it will report its first quarter fiscal 2027 financial results after market close on September 14, 2026.4d ago

Kestra Medical Technologies signed a five-year $200 million senior secured term loan facility, with $75 million Tranche A funded at closing and proceeds used for general corporate needs and repayment of prior debt.53d ago

Similar companies

PW Medtech Group Limited01358.HK 爱威科技688067.SH Azenta, Inc.AZTA BioLife Solutions, Inc.BLFS 安必平688393.SH LeMaitre Vascular, Inc.LMAT Find similar companies →

Latest newsMore news →

Kestra Medical Technologies announced it will report its first quarter fiscal 2027 financial results after market close on September 14, 2026.4d ago Kestra Medical Technologies signed a five-year $200 million senior secured term loan facility, with $75 million Tranche A funded at closing and proceeds used for general corporate needs and repayment of prior debt.53d ago